The 12 closest competitors and alternatives to Molecule.one among biotechnology companies — ranked by similarity to what Molecule.one actually does, not by market-cap band.
Subscribe to see Molecule.one’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Molecule.one is a chemistry artificial intelligence company that develops autonomous discovery software for chemical research. Headquartered in Portola Valley, California, the company operates research and technical facilities to accelerate laboratory workflows.
Molecule.one is a biotechnology company headquartered in Poland. It has raised at least $5.6M across the 2 funding rounds on record. Its most recent funding round, Pre-seed, raised $1M in July 2026. Xcout tracks 5 named people at Molecule.one, including Dr. Piotr Byrski (CEO and Co-Founder).
At least $5.6M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-seed | $1M | 8 named | |
| Seed | $4.6M | 8 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Molecule.one by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Aether Bio is a biotechnology company headquartered in Menlo Park, California, that develops AI-designed molecular machines. Utilizing its Protein Function Model, the company accelerates protein discovery for advanced manufacturing, super materials, and critical mineral processing.
Similar biotechnology company
Cime Therapeutics Inc. is a chemistry-first company that provides an automated synthesis platform integrating artificial intelligence and machine learning for drug discovery. The company serves the pharmaceutical and biotechnology sectors by producing novel therapeutic molecules, such as small molecules, molecular glues, and covalent compounds, at high speed and scale.
Biotech
Atomic AI is a biotechnology research company specializing in RNA drug discovery utilizing atomic precision. Headquartered in San Francisco, California, the company combines machine learning and biology to develop advanced therapeutics.
Similar biotechnology company
Noetik Inc. is an AI-native biotechnology company headquartered in South San Francisco, California, leveraging advanced machine learning methods for biological discovery.
Biotech
Insitro is a physical artificial intelligence company headquartered in South San Francisco, California, that uses machine learning and data at scale to build a different kind of drug company.
Similar biotechnology company
Avicenna Biosciences, Inc. is a biotechnology company that uses machine learning-enhanced medicinal chemistry to accelerate drug discovery and optimization.
Biotech
Chai Discovery is a technology company that maintains an office in San Francisco. The company hires for roles such as software engineers and forward-deployed scientists to work on its platform and products.
Life Sciences & Technology
Exscientia Inc. is a company based in Miami, Florida, United States. It is at the forefront of artificial intelligence (AI)-driven drug discovery and design, fusing AI power with discovery experience.
Biotech
Enveda Biosciences (Enveda Therapeutics Inc.) is a biotechnology research company headquartered in Boulder, Colorado. The company leverages artificial intelligence to discover novel therapeutics and chemical compounds derived from natural sources.
Biotech
AbInitio Bio is developing the first foundation models specifically for biomanufacturing. The company is headquartered in San Francisco.
Biotech
Metis TechBio Co., Ltd., founded in 2020 and headquartered in Beijing, China, (previously Hangzhou Jitai Pharmaceutical Technology Co., Ltd.) specializes in the advanced research and development of AI-powered nanomaterials. The company's core mission is to facilitate the delivery and application of active agents within carbon-based life forms, operating in both the Chinese Mainland and the United States. Central to its offerings is NanoForge, a comprehensive suite of interconnected technologies that includes a novel lipid library, foundational artificial intelligence models, METiSAIAgent, cutting-edge quantum chemistry and molecular dynamics simulations, and AI-driven screening platforms. Furthermore, Metis TechBio has developed specialized platforms like AiTEM, AiLNP, and AiRNA. These tools are crucial for simulating, predicting, and interpreting interactions at the nanoscale, thereby enabling the precise design, optimization, and validation of sophisticated nanomaterials and their associated payloads. The company provides its services through a three-tiered system: a foundational dry-wet data layer supported by integrated laboratory infrastructure, a model layer featuring METiS AI foundational models, and an application layer known as METiSAgentv. Metis TechBio primarily serves a diverse clientele, including pharmaceutical companies, biotechnology firms, and medical research institutions.
Biotech
Launched in 2022 and headquartered in Seattle, Washington, Vilya is an AI peptide company co-founded by scientists from the Institute of Protein Design. The company uses artificial intelligence and synthetic biology to design novel macrocycle therapeutics inspired by nature.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Molecule.oneand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →